Voting Rights and Capital

1 Mar 2007 10:40

Ark Therapeutics Group PLC01 March 2007 1 March 2007 Ark Therapeutics Group plc Voting Rights and Capital In conformity with the Transparency Directive's transitional provision 6, ArkTherapeutics Group plc (LSE: AKT) ("Ark" or the "Company") announces that theCompany's capital consists of 165,945,358 ordinary shares with voting rights.This figure may be used by shareholders as the denominator for the calculationsby which they will determine if they are required to notify their interest in,or a change to the interest in, Ark under the FSA's Disclosure and TransparencyRules. - Ends - This information is provided by RNS The company news service from the London Stock Exchange